Laxoberal

Sodium Picosulfate, the active ingredient in Laxoberal, is a stimulant laxative presented as an oral formulation for oral use. It is employed to relieve constipation and to prepare the bowel for diagnostic procedures such as colonoscopy.

GNH USA supplies Laxoberal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laxoberal, a stimulant laxative, is indicated for conditions affecting bowel motility and preparation. - Constipation: promotes bowel movements to relieve occasional or chronic constipation. - Bowel preparation for colonoscopy: clears the colon to enable clear visualization during colonoscopic examination. - Bowel preparation for other diagnostic procedures: facilitates intestinal cleansing required before certain radiologic or endoscopic studies.

Adverse reactions may occur with any stimulant laxative and are categorized by frequency.

Common Side Effects: - Abdominal cramps: mild to moderate discomfort in the abdomen. - Diarrhea: loose, watery stools occurring after dosing. - Nausea: feeling of queasiness without vomiting. - Flatulence: increased intestinal gas. - Thirst: sensation of needing fluids. - Headache: mild headache not requiring medical attention.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss requiring medical evaluation. - Electrolyte disturbances (e.g., hypokalemia): abnormal blood electrolyte levels. - Rectal bleeding: visible blood in stool. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: intense pain that may indicate complications. - Colonic perforation: rare but serious tear in the colon wall.

Before initiating therapy, consider the following safety measures. - Assess bowel function: ensure patient has not recently used other laxatives. - Avoid in intestinal obstruction: contraindicated when blockage is present. - Do not use with acute abdominal pain: may worsen underlying condition. - Caution in elderly: increased susceptibility to fluid and electrolyte loss. - Monitor electrolytes: especially with prolonged use or high doses. - Store at room temperature: keep in the original pack, protect from moisture.

Sodium Picosulfate may interact with other medicines, requiring attention to avoid reduced efficacy or increased risk.

Major Interactions (Avoid): - Anticholinergic agents: may diminish laxative effect. - Opioid analgesics: counteract stimulant action on the bowel. - Antidiarrheal drugs (e.g., loperamide): oppose intended increase in motility.

Moderate Interactions (Monitor Closely): - Diuretics: potential for additive electrolyte loss. - Cardiac glycosides (e.g., digoxin): monitor for electrolyte‑related toxicity. - Corticosteroids: may increase risk of gastrointestinal irritation.